| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/22/2001 | WO2001012210A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | WO2001012203A1 Method of preventing adhesions with absorbable polyoxaesters |
| 02/22/2001 | WO2001012201A1 Blood plasma replacement solution |
| 02/22/2001 | WO2001012200A1 An oral composition comprising coenzyme a for treating hyperlipemia, the preparation method and the use thereof |
| 02/22/2001 | WO2001012193A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 02/22/2001 | WO2001012181A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 02/22/2001 | WO2001012179A1 Ophthalmic fluid |
| 02/22/2001 | WO2001012175A1 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 02/22/2001 | WO2001012170A2 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 02/22/2001 | WO2001012165A1 Rolled external-use patch |
| 02/22/2001 | WO2001012164A1 Oral form of administration containing probiotic micro-organisms |
| 02/22/2001 | WO2001012162A1 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof |
| 02/22/2001 | WO2001012161A1 Rapidly dissolving dosage form and process for making same |
| 02/22/2001 | WO2001012160A1 Microparticles for pulmonary administration |
| 02/22/2001 | WO2001012159A2 Artificial tear replacement solution |
| 02/22/2001 | WO2001012158A1 Implantable drug delivery catheter system with capillary interface |
| 02/22/2001 | WO2001012157A1 Thermally-activated microchip chemical delivery devices |
| 02/22/2001 | WO2001012156A1 Topical organic ectoparasiticidal formulations |
| 02/22/2001 | WO2001012155A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | WO2001012154A2 Targeted lipid particles |
| 02/22/2001 | WO2001012112A2 Prevention of posterior capsular opacification |
| 02/22/2001 | WO2001012106A1 Composite shaped bodies and methods for their production and use |
| 02/22/2001 | WO2001012103A1 Metering and packaging of controlled release medication |
| 02/22/2001 | WO2001012069A1 Hollow microspheres with controlled fragility for medical use |
| 02/22/2001 | WO2001011964A1 Ectoparasiticidal aqueous suspension formulations of spinosyns |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000075281A9 Supercritical fluid-assisted nebulization and bubble drying |
| 02/22/2001 | WO2000074677A3 Improved pharmaceutical formulations |
| 02/22/2001 | WO2000069470A3 Improved cellular uptake of bioactive agents |
| 02/22/2001 | WO2000067724A3 Gastroretentive system for an extended retention time in the stomach or in the gastro-intestinal tract |
| 02/22/2001 | WO2000063385A3 Nucleic acid immunization |
| 02/22/2001 | WO2000057853A3 Pharmaceutical composition containing an extrusion additive |
| 02/22/2001 | WO2000048642B1 Biocompatible material with a novel functionality |
| 02/22/2001 | WO2000023065A8 Storable active substance concentrate with formoterol |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | DE19939139A1 Emulgatorfreie feindisperse Systeme vom Typ Wasser-in-Öl Emulsifier-free finely dispersed systems of the water-in-oil |
| 02/22/2001 | DE19938823A1 Treatment of restless leg syndrome symptoms, using synergistic combination of alpha-2 agonist, preferably clonidine, and another neuro-psychic drug, e.g. pramipexol |
| 02/22/2001 | DE19938800A1 Preparation for efficiently transporting volatile agents, e.g. drugs or pesticides, through barriers, e.g. skin or mucosa, containing permeation promoter, e.g. transfersomes |
| 02/22/2001 | DE19938668A1 Tränenersatzmittel Artificial tears |
| 02/22/2001 | DE19938371A1 Lipid particles based on matrix comprising solid and liquid lipid, useful in diagnostics and for controlled release of active agents, especially pharmaceuticals |
| 02/22/2001 | DE19937361A1 Orale Darreichungsform The oral dosage form |
| 02/22/2001 | CA2689735A1 Compositions comprising modafinil for treatment of fatigue associated with multiple sclerosis |
| 02/22/2001 | CA2452118A1 Pharmaceutical compositions for oral and topical administration |
| 02/22/2001 | CA2381951A1 Thermally-activated microchip chemical delivery devices |
| 02/22/2001 | CA2380966A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | CA2380941A1 Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| 02/22/2001 | CA2380928A1 Method of preventing adhesion with absorbable polyoxaesters |
| 02/22/2001 | CA2380908A1 Plasma substitute composition |
| 02/22/2001 | CA2380883A1 Microparticles for pulmonary administration |
| 02/22/2001 | CA2380741A1 An ophthalmic fluid for contact lenses comprising a glyceride |
| 02/22/2001 | CA2380699A1 Implantable drug delivery catheter system with capillary interface |
| 02/22/2001 | CA2380653A1 Mycophenolate mofetil in association with peg-ifn-.alpha. |
| 02/22/2001 | CA2380643A1 Topical organic ectoparasiticidal formulations |
| 02/22/2001 | CA2380642A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | CA2380598A1 Composite shaped bodies and method for their production and use |
| 02/22/2001 | CA2380596A1 Metering and packaging of controlled release medication |
| 02/22/2001 | CA2380517A1 Targeted artificial gene delivery |
| 02/22/2001 | CA2380449A1 Rapidly dissolving dosage form and process for making same |
| 02/22/2001 | CA2380432A1 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 02/22/2001 | CA2379431A1 Targeted lipid particles |
| 02/22/2001 | CA2379196A1 Rotavirus vaccine formulations |
| 02/22/2001 | CA2378708A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 02/22/2001 | CA2377415A1 An oral administration form |
| 02/21/2001 | WO2001007012A1 Strip pack |
| 02/21/2001 | EP1077070A2 Oral drug delivery compositions |
| 02/21/2001 | EP1077067A1 Stabilized cefuroxime axetil |
| 02/21/2001 | EP1077066A1 Preventives/remedies for skin diseases |
| 02/21/2001 | EP1077065A1 Regulated release preparations |
| 02/21/2001 | EP1077061A2 Use of peroxidised lipids for treating or preventing mucosal wounds and inflammations of the oral cavity |
| 02/21/2001 | EP1077058A2 Finely dispersed system of the type water-in-oil without emulsifiers |
| 02/21/2001 | EP1076671A1 Non cross-linked block polyetherester, preparation and uses |
| 02/21/2001 | EP1076562A1 Glucocorticoid receptor antagonists for the treatment of dementia |
| 02/21/2001 | EP1076555A1 Pectic preparations used as medicine carrier |
| 02/21/2001 | EP1076534A2 Stent with smooth ends |
| 02/21/2001 | EP0988029A4 Device and methods for wound treatment |
| 02/21/2001 | EP0975609A4 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| 02/21/2001 | EP0835238B1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 02/21/2001 | EP0735866B1 Antimicrobial wipe compositions |
| 02/21/2001 | CN1284883A Method to enhance an immune response of nucleic acid vaccination |
| 02/21/2001 | CN1284880A Hyperhydrated citicoline, process and use |
| 02/21/2001 | CN1284877A Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations |
| 02/21/2001 | CN1284873A Water-base liquid preparation |
| 02/21/2001 | CN1284870A Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 02/21/2001 | CN1284869A Treatment of chronic inflammatory disorders of gastrointestinal tract |
| 02/21/2001 | CN1284868A Oral pharmaceutical pulsed release dosage form |
| 02/21/2001 | CN1284867A Process for manufacturing bite-dispersion tablets |
| 02/21/2001 | CN1284866A Oral pharmaceutical extended release dosage form |
| 02/21/2001 | CN1284865A Pharmaceutical compositions containing micronized bicyclic drugs |
| 02/21/2001 | CN1284864A Novel formulation for use in pain management |
| 02/21/2001 | CN1284863A Topical compositions for NSAI drug delivery |
| 02/21/2001 | CN1284862A Topical compositions for prostaglandin E1 delivery |
| 02/21/2001 | CN1284861A Novel pharmaceutical compositions of uridine triphosphate |
| 02/21/2001 | CN1284860A Microparticles and their therapeutic or diagnostic use |
| 02/21/2001 | CN1284372A 'Sanhuangqinbao' powder-medicine for chicken |
| 02/21/2001 | CN1284351A Red sage containing medicine composition and its preparation and use |
| 02/21/2001 | CN1284350A Preparation of Chinese medicine pill for external use in acupoint |
| 02/21/2001 | CN1284348A Liver protecting and pus drawing out ointment and its preparation |
| 02/21/2001 | CN1284346A Far infrared Gukangtie plaster |
| 02/21/2001 | CN1284340A Production process of biologically active woodfrog fat capsule |
| 02/21/2001 | CN1284333A Application of isopropylfuran in preparing hepatitis B virus resisting medicine |